2025年国家医保药品目录公布 图解114种新增药品

Core Insights - The National Healthcare Security Administration (NHSA) has released the 2025 National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog, along with the 2025 Commercial Health Insurance Innovative Drug Catalog, highlighting significant updates in drug listings and coverage [1][4]. Summary by Categories National Medical Insurance Drug Catalog - A total of 114 new drugs have been added to the National Medical Insurance Drug Catalog, with 50 classified as Class 1 innovative drugs, achieving an overall success rate of 88%, an increase from 76% in 2024 [1]. - The total number of drugs in the updated catalog has risen to 3,253, comprising 1,857 Western medicines and 1,396 traditional Chinese medicines, with enhanced coverage for critical areas such as oncology, chronic diseases, mental health, rare diseases, and pediatric medications [1]. Commercial Health Insurance Innovative Drug Catalog - The first edition of the Commercial Health Insurance Innovative Drug Catalog includes 19 new drugs, focusing on those with significant clinical value, high innovation levels, and clear patient benefits, which exceed the basic medical insurance coverage [2]. - The inclusion process involved self-reporting, expert reviews, and price negotiations, resulting in 19 drugs from 18 innovative pharmaceutical companies being successfully listed [2].